Dr Martens (LSE:DOCS) has reiterated its guidance for the 2027 financial year in a trading update, alongside its annual general meeting later today in London.
The bootmaker said it remains on track with the strategic objectives it has set across its consumer, product, markets and organisation priorities.
The United States, Dr Martens' largest market, continues to grow, with wholesale demand "particularly encouraging".
Japan and South Korea, its largest markets in Asia, are also performing well, while European markets are trading in line with expectations against what the company called a "challenging consumer backdrop".
